CAR T-cell therapy, SEM

sursa imaginii https://www.quantamagazine.org/james-p-allison-and-tasuku-honjo-win-nobel-prize-for-cancer-immunotherapy-20181001/

T-cells and breast cancer cell. Composite conceptual coloured scanning electron micrograph (SEM) of T-cells and a breast cancer cell (pink). CAR T-cell therapy involves producing large quantities of specialised T-cells on an individual basis for each patient. T-cells are extracted from a patient’s blood sample and reprogrammed to recognise a specific target protein on the patient’s tumour cells. To achieve this, the T-cells are infected with a harmless virus, which inserts a gene into the T-cell’s DNA that causes the T-cell to produce a receptor on its surface that recognises a specific tumour protein. Large quantities of the reprogrammed T-cells are grown in the lab before being injected back into the patient where they seek out the target protein on breast cancer cells and attack them.

Bookmark the permalink.

Leave a Reply

Your email address will not be published. Required fields are marked *